| 23/03/22 | 17:03:26 | 23 Mar 2022 | | Director/PDMR Shareholding |
| 23/03/22 | 07:00:05 | 23 Mar 2022 | | Issuance of Notes |
| 16/03/22 | 14:40:34 | 16 Mar 2022 | | Director/PDMR Shareholding |
| 15/03/22 | 14:45:52 | 15 Mar 2022 | | Director/PDMR Shareholding |
| 15/03/22 | 10:00:02 | 15 Mar 2022 | | Appointments to Designate Haleon Board |
| 11/03/22 | 14:55:49 | 11 Mar 2022 | | Director/PDMR Shareholding |
| 09/03/22 | 13:44:37 | 9 Mar 2022 | | Director/PDMR Shareholding |
| 08/03/22 | 18:24:12 | 8 Mar 2022 | | GSK Annual Report 2021 on Form 20-F |
| 04/03/22 | 11:03:50 | 4 Mar 2022 | | GSK publishes Annual Report 2021 |
| 01/03/22 | 14:30:15 | 1 Mar 2022 | | Total Voting Rights |
| 01/03/22 | 13:18:53 | 1 Mar 2022 | | Director/PDMR Shareholding |
| 01/03/22 | 09:55:43 | 1 Mar 2022 | | Director/PDMR Shareholding |
| 01/03/22 | 07:00:05 | 1 Mar 2022 | | Daprodustat application accepted for review by EMA |
| 28/02/22 | 11:00:02 | 28 Feb 2022 | | GSK introduces Haleon to investors |
| 28/02/22 | 07:00:07 | 28 Feb 2022 | | GSK RSV maternal vaccine candidate further update |
| 24/02/22 | 16:22:10 | 24 Feb 2022 | | Director/PDMR Shareholding |
| 24/02/22 | 15:12:57 | 24 Feb 2022 | | Canada Approval For Medicago GSK Covid-19 Vaccine |
| 23/02/22 | 14:50:13 | 23 Feb 2022 | | Director/PDMR Shareholding |
| 22/02/22 | 14:00:00 | 22 Feb 2022 | | GSK Consumer Healthcare to be called Haleon |
| 22/02/22 | 09:22:02 | 22 Feb 2022 | | Director/PDMR Shareholding |
| 18/02/22 | 16:30:47 | 18 Feb 2022 | | Director/PDMR Shareholding |
| 18/02/22 | 07:00:09 | 18 Feb 2022 | | GSK gives update on RSV maternal vaccine candidate |
| 17/02/22 | 16:00:07 | 17 Feb 2022 | | Director/PDMR Shareholding |
| 17/02/22 | 15:40:07 | 17 Feb 2022 | | Director/PDMR Shareholding |
| 17/02/22 | 15:20:07 | 17 Feb 2022 | | Director/PDMR Shareholding |
| 17/02/22 | 14:50:06 | 17 Feb 2022 | | Director/PDMR Shareholding |
| 17/02/22 | 14:19:13 | 17 Feb 2022 | | Director/PDMR Shareholding |
| 16/02/22 | 18:04:29 | 16 Feb 2022 | | Director/PDMR Shareholding |
| 14/02/22 | 17:50:29 | 14 Feb 2022 | | Director/PDMR Shareholding |
| 14/02/22 | 13:26:53 | 14 Feb 2022 | | Transfer of Treasury Shares |
| 11/02/22 | 14:06:36 | 11 Feb 2022 | | Director/PDMR Shareholding |
| 11/02/22 | 09:33:46 | 11 Feb 2022 | | Director/PDMR Shareholding |
| 10/02/22 | 09:00:02 | 10 Feb 2022 | | Benlysta approved in China for Lupus Nephritis |
| 09/02/22 | 11:07:38 | 9 Feb 2022 | | Director/PDMR Shareholding |
| 09/02/22 | 07:00:07 | 9 Feb 2022 | | Final Results |
| 07/02/22 | 10:30:58 | 7 Feb 2022 | | Publication of full year 2021 results: Replacement |
| 07/02/22 | 10:00:01 | 7 Feb 2022 | | Publication of full year 2021 results |
| 02/02/22 | 07:00:05 | 2 Feb 2022 | | GSK announces settlement between ViiV and Gilead |
| 01/02/22 | 13:44:38 | 1 Feb 2022 | | FDA approves ViiV Healthcare’s sNDA for Cabenuva |
| 01/02/22 | 11:44:03 | 1 Feb 2022 | | Total Voting Rights |
| 26/01/22 | 16:48:03 | 26 Jan 2022 | | Director/PDMR Shareholding |
| 20/01/22 | 15:59:20 | 20 Jan 2022 | | Director/PDMR Shareholding |
| 19/01/22 | 16:33:13 | 19 Jan 2022 | | Director/PDMR Shareholding |
| 19/01/22 | 15:14:38 | 19 Jan 2022 | | Director/PDMR Shareholding |
| 19/01/22 | 15:10:04 | 19 Jan 2022 | | Director/PDMR Shareholding |
| 19/01/22 | 07:00:57 | 19 Jan 2022 | | Tony Wood appointed CSO Designate, GSK |
| 17/01/22 | 17:04:18 | 17 Jan 2022 | | Director/PDMR Shareholding |
| 17/01/22 | 15:07:50 | 17 Jan 2022 | | Director/PDMR Shareholding |
| 17/01/22 | 07:00:05 | 17 Jan 2022 | | Update - GSK Consumer Healthcare |
| 14/01/22 | 15:22:51 | 14 Jan 2022 | | Director/PDMR Shareholding |
